Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome-Reference-Cited by-同舟云学术

Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome

Published:1995-07 Issue:2 Volume:82 Page:116-122
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Fagioli Franca,Cuneo Antonio,Bardi Antonella,Carli Maria Gretel,Bigoni Renato,Balsamo Rosa,Previati Rita,Pazzi Isabella,Roberti Grazia,Rigolin Gian Matteo,Castoldi Gianluigi

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference30 articles.

1. Cytogenetics;Mecucci;Myelodysplastic Syndrome, Hematol Oncol Clin N Am,1992

2. Proposal for the classification of the myelodysplastic syndromes;Bennet;Br J Haematol,1982

3. Cytogenetic and cytochemical studies on progenitor cells of primary acquired sideroblastic anemia (PASA): involvement of multipotent myeloid stem cells in PASA clone and mosaicism with normal clone;Amenomori;Blood,1987

4. Cytogenetic analysis of different cellular populations in chronic myelomonocytic leukemia;Cuneo;Cancer Genet Cytogenet,1989

5. Cell lineage involvement in four patients with myelodysplastic syndrome and t(15;17) or trisomy 8 studied by simultaneous immunophenotyping and fluorescent in situ hybridization;Nylund;Cancer Genet Cytogenet,1993

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?;PLOS ONE;2015-06-12

2. Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting;Leukemia Research;2007-09

3. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes;Pathologie Biologie;2007-02

4. Genetic Testing in the Myelodysplastic Syndromes: Molecular Insights Into Hematologic Diversity;Mayo Clinic Proceedings;2005-05

5. Engraftment of NOD/SCID-β2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome;Blood;2004-06-01